Earth Science Tech, Inc. (ETST)
OTCMKTS · Delayed Price · Currency is USD
0.1862
-0.0065 (-3.37%)
Sep 9, 2025, 3:29 PM EDT
Earth Science Tech Revenue
Earth Science Tech had revenue of $8.76M in the quarter ending June 30, 2025, with 2.23% growth. This brings the company's revenue in the last twelve months to $33.31M, up 64.06% year-over-year. In the fiscal year ending March 31, 2025, Earth Science Tech had annual revenue of $33.12M with 177.05% growth.
Revenue (ttm)
33.31M
Revenue Growth
+64.06%
P/S Ratio
1.65
Revenue / Employee
438.27K
Employees
76
Market Cap
54.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 33.12M | 21.16M | 177.05% |
| Mar 31, 2024 | 11.95M | 11.91M | 24,527.88% |
| Mar 31, 2023 | 48.54K | 34.41K | 243.67% |
| Mar 31, 2022 | 14.12K | -126.78K | -89.98% |
| Mar 31, 2021 | 140.90K | -385.24K | -73.22% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
Earth Science Tech News
- 20 days ago - Earth Science Tech expands share buyback to $10M, extends program through 2027 - Seeking Alpha
- 20 days ago - Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027 - GlobeNewsWire
- 21 days ago - Earth Science Tech board approves reduction of authorized common stock - Seeking Alpha
- 21 days ago - Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock - GlobeNewsWire
- 4 weeks ago - Earth Science Tech reports Q1 results - Seeking Alpha
- 4 weeks ago - Earth Science Tech, Inc. Reports 61% Asset Growth to $7.69 Million and $8.7 Million in First Quarter Revenue Following Foundational Quarter of Strategic Acquisitions - GlobeNewsWire
- 2 months ago - Earth Science Tech, Inc. Qualifies for and Joins New OTCID Tier - GlobeNewsWire
- 2 months ago - Earth Science Tech reports FY results - Seeking Alpha